Medical News

RSS

Celsius Holdings introduces calorie burning beverage in New York and Pennsylvania

Celsius Holdings, Inc. (OTCBB: CSUH) announced today that Celsius®, the original calorie burning beverage, is now available at all 76 Tops Friendly Markets locations in New York and Pennsylvania.

25 Aug 2009

State of Arizona offers BCBSAZ network option to its employees and their families

Blue Cross Blue Shield of Arizona (BCBSAZ) is pleased to announce the State of Arizona is offering a BCBSAZ network option to approximately 65,000 state employees and their families during the upcoming health insurance open enrollment period.

25 Aug 2009

Engageon releases its first installation of the Engageon Association Builder software

In response to the quickly emerging need for associations and other organizations to deploy social networking tools for their members or constituents, tech startup Engageon LLC officially released its first installation of the Engageon Association Builder (EAB). The first launch was developed for the National Lipid Association (NLA).

25 Aug 2009

PacifiCord to conduct free prenatal classes in San Diego from September 2009

Dedicated to serving the private cord blood banking needs of Southern California, PacifiCord (www.pacificord.com) today announced it will be offering free prenatal classes in San Diego starting September 9, 2009.

25 Aug 2009

FDA issues final approval for manufacturing and marketing Ranbaxy's Glycopyrrolate tablets

Ranbaxy Pharmaceuticals Inc. (RPI), a wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL), announced today that RLL has received approval from the U.S. Food and Drug Administration to manufacture and market Glycopyrrolate Tablets USP, 1 mg and 2 mg.

25 Aug 2009

Thyretain TSI Reporter BioAssay test for detecting auto-antibodies attains the FDA clearance

Diagnostic HYBRIDS announces the FDA clearance, for marketing under the 510(k) pre-notification process, of the Thyretain TSI Reporter BioAssay. Thyretain is an in vitro diagnostic use test that specifically detects auto-antibodies called thyroid stimulating immunoglobulins (TSI) in patient serum.

25 Aug 2009

Senate Democrats plot new strategy, consider reconciliation to pass health bill

Senate Democrats are increasingly considering using budget reconciliation — which would need a simple majority of 51 votes — to pass health care reform without Republican support, The New York Times reports.

25 Aug 2009

New minimally invasive procedure to treat ruptured brain aneurysm developed

Researchers in Finland have identified an effective new treatment option for patients who have suffered a ruptured brain aneurysm, a potentially life-threatening event. Results of the new study on stent-assisted coil embolization were published today in the online edition of Radiology.

25 Aug 2009

Myoderm expands its portfolio to include drug procurement, management and distribution services

Myoderm, a leading global pharmaceutical supplier of comparator drugs for clinical research and clinical trials, has expanded its portfolio to include Distribution Management Services. This new capability provides their clients with an efficient solution for sourcing, managing, and distributing off-the-shelf, commercial drugs used in clinical trials.

25 Aug 2009

Neurogen stockholders to receive $11 million in Ligand Pharmaceuticals common stock as part of acquisition deal

Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) and Neurogen Corporation (NASDAQ:NRGN) announced today they have entered into a definitive merger agreement under which Ligand will acquire Neurogen. Under the transaction, Neurogen stockholders will receive an estimated $11 million in Ligand common stock and will be granted Contingent Value Rights (“CVRs”) under four CVR agreements.

25 Aug 2009

Insurers seek savings by offering coverage for care in other countries

More insurers are offering networks of doctors overseas and in other countries for their policyholders as a way to save money as lawmakers struggle with how to drive down costs, The Associated Press/USA Today reports.

25 Aug 2009

UCB and sanofi-aventis U.S. receive FDA's approval for XYZAL to treat allergies in children

UCB and sanofi-aventis U.S. announced today that the U.S. Food and Drug Administration (FDA) has approved XYZAL(R) (levocetirizine dihydrochloride) for children age six months and older for the relief of symptoms of perennial allergic rhinitis (indoor allergies) and chronic idiopathic urticaria (chronic hives) and for children age two years and older for symptoms of seasonal allergic rhinitis (outdoor allergies).

25 Aug 2009

Insurance industry may benefit from reform, employees attend town halls to counter criticism

Lashed by liberals and threatened with more government regulation, the insurance industry nevertheless rallied its lobbying and grass-roots resources so successfully in the early stages of the healthcare overhaul deliberations that it is poised to reap a financial windfall," The Los Angeles Times reports.

25 Aug 2009

Milestone Scientific receives Notice of Allowance to use disposable hand piece for fluid administration

Milestone Scientific Inc. (OTC Bulletin Board: MLSS), the recognized leader in advanced injection technologies, today announced that the United States Patent and Trademark Office has issued a Notice of Allowance for Milestone's U.S. patent application directed to the use of its disposable hand piece for fluid administration.

25 Aug 2009

FDA issues marketing approval for APP Pharmaceuticals' Penicillin G potassium for Injection, USP

APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc. (NASDAQ: APCVZ), announced today that it has received approval from the U.S. Food and Drug Administration (FDA) to market penicillin G potassium for Injection, USP, in two dosage strengths. Penicillin G is therapeutically equivalent to the reference drug PfizerPen™ G, which is marketed by the innovator Pfizer, Inc.

25 Aug 2009

Ecology Coatings collaborates with a tobacco company for producing fire standard compliant cigarettes

Ecology Coatings, Inc., a leader in the discovery and development of nanotechnology-enabled, ultraviolet-curable advanced coatings, today announced that it has signed a collaboration agreement with a major tobacco company for the application of its technology for producing "fire standard compliant" (FSC) cigarettes.

25 Aug 2009

NIAID funds Nanotherapeutic for developing an inhaled version of the injectable antiviral drug

Nanotherapeutics, Inc., today announced that it has been awarded a $30.9 Million, 5-year contract from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to develop an inhaled version of the injectable antiviral drug, cidofovir, for non-invasive, post-exposure prophylaxis and treatment of the Category A bioterrorism agent smallpox (Variola major).

25 Aug 2009

Study suggests that artificially sweetened beverages may help to control weight

A new study published in the International Journal of Obesity reports that consumption of sugar-free beverages sweetened with low-calorie sweeteners increases dietary restraint, a key aspect of successful weight maintenance.

25 Aug 2009

Rising costs and patient loads push some primary care MDs to concierge practices

Some primary care doctors are changing their practices, The Philadelphia Inquirer reports: "Faced with rising costs and patient loads, a small but growing number of primary-care doctors are sharply reducing their practice sizes and charging each patient annual fees of about $2,000 in exchange for personalized care.

25 Aug 2009

FDA approves new model of ZOLL's LifeVest wearable defibrillator

ZOLL Medical Corporation (Nasdaq GS: ZOLL), a manufacturer of resuscitation devices and related software solutions, has received approval from the U.S. Food and Drug Administration (FDA) to market and sell a new model of the LifeVest® wearable defibrillator.

25 Aug 2009

Medical News

Celsius Holdings introduces calorie burning beverage in New York and Pennsylvania

State of Arizona offers BCBSAZ network option to its employees and their families

Engageon releases its first installation of the Engageon Association Builder software

PacifiCord to conduct free prenatal classes in San Diego from September 2009

FDA issues final approval for manufacturing and marketing Ranbaxy's Glycopyrrolate tablets

Thyretain TSI Reporter BioAssay test for detecting auto-antibodies attains the FDA clearance

Senate Democrats plot new strategy, consider reconciliation to pass health bill

New minimally invasive procedure to treat ruptured brain aneurysm developed

Myoderm expands its portfolio to include drug procurement, management and distribution services

Neurogen stockholders to receive $11 million in Ligand Pharmaceuticals common stock as part of acquisition deal

Insurers seek savings by offering coverage for care in other countries

UCB and sanofi-aventis U.S. receive FDA's approval for XYZAL to treat allergies in children

Insurance industry may benefit from reform, employees attend town halls to counter criticism

Milestone Scientific receives Notice of Allowance to use disposable hand piece for fluid administration

FDA issues marketing approval for APP Pharmaceuticals' Penicillin G potassium for Injection, USP

Ecology Coatings collaborates with a tobacco company for producing fire standard compliant cigarettes

NIAID funds Nanotherapeutic for developing an inhaled version of the injectable antiviral drug

Study suggests that artificially sweetened beverages may help to control weight

Rising costs and patient loads push some primary care MDs to concierge practices

FDA approves new model of ZOLL's LifeVest wearable defibrillator

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News